| KOTAK CONTRA FUND
An open ended equity Scheme following contrarian investment strategy
An open ended equity Scheme following contrarian investment strategy
| KOTAK CONTRA FUND
An open ended equity Scheme following contrarian investment strategy
(as on February 27, 2026)
Source: $ICRA MFI Explorer, ^^Bloomberg
***As per para 1.9 of of SEBI Master c***As per para 1.9 of of SEBI Master circular No. SEBI/HO/IMD/IMD-PoD-1/P/CIR/2024/90 dated June 27, 2024 The first tier benchmark is reflective of the category of the scheme and the second tier benchmark is demonstrative of the investment style / strategy of the Fund Manager within the category.
## Risk rate assumed to be 5.17% (FBIL Overnight MIBOR rate as on 27th Feb 2026).**Total Expense Ratio includes applicable B30 fee and GST.
* For Fund Manager experience, please refer 'For Regular Plan' & 'For Direct Plan'
For last three IDCW, please refer 'Dividend History'.
For scheme performance, please refer 'For Regular Plan' & 'For Direct Plan'
An open ended equity Scheme following contrarian investment strategy
 |
 |
  
|
|
|
|
Investment Objective
The investment objective of the Scheme is to generate capital appreciation from a diversified portfolio of equity and equity related instruments.
The Scheme will invest in stocks of companies, which are fundamentally sound but are undervalued. Undervalued stocks are stocks of those companies whose true long
term potential is not yet recognised by the market. At times, the broad market takes time to appreciate the long-term potential of some fundamentally sound
companies. Stocks of such companies are traded at prices below their intrinsic value and are regarded as undervalued stocks. We believe that, over a period of time, the
price of a stock reflects the intrinsic value of the underlying company. Thus, the moving up of the price of the undervalued stock towards its intrinsic value will help us
generate capital appreciation for investors. There is no assurance that the investment objective of the Scheme will be achieved.
The investment objective of the Scheme is to generate capital appreciation from a diversified portfolio of equity and equity related instruments.
The Scheme will invest in stocks of companies, which are fundamentally sound but are undervalued. Undervalued stocks are stocks of those companies whose true long
term potential is not yet recognised by the market. At times, the broad market takes time to appreciate the long-term potential of some fundamentally sound
companies. Stocks of such companies are traded at prices below their intrinsic value and are regarded as undervalued stocks. We believe that, over a period of time, the
price of a stock reflects the intrinsic value of the underlying company. Thus, the moving up of the price of the undervalued stock towards its intrinsic value will help us
generate capital appreciation for investors. There is no assurance that the investment objective of the Scheme will be achieved.
| Issuer/Instrument | % to Net Assets |
|
|---|---|---|
| Equity & Equity related | ||
| Banks | 23.05 | |
| HDFC Bank Ltd. | 5.82 | |
| ICICI Bank Ltd. | 4.61 | |
| STATE BANK OF INDIA | 4.18 | |
| Axis Bank Ltd. | 2.02 | |
| Bank Of Baroda | 1.61 | |
| IndusInd Bank Ltd. | 1.51 | |
| INDIAN BANK | 1.40 | |
| BANK OF MAHARASHTRA | 1.32 | |
| KOTAK MAHINDRA BANK LTD. | 0.58 | |
| Finance | 9.16 | |
| SHRIRAM FINANCE LTD. | 3.26 | |
| POONAWALLA FINCORP LTD. | 2.13 | |
| BAJAJ FINANCE LTD. | 2.06 | |
| APTUS VALUE HOUSING FINANCE | 0.87 | |
| PIRAMAL FINANCE LTD | 0.84 | |
| IT - Software | 6.71 | |
| Infosys Ltd. | 2.82 | |
| Mphasis Ltd | 1.99 | |
| Tech Mahindra Ltd. | 1.90 | |
| Healthcare Services | 5.93 | |
| Fortis Healthcare India Ltd | 2.41 | |
| PARK MEDI WORLD LIMITED (PARK HOSPITAL) | 1.46 | |
| Global Health Ltd. | 1.10 | |
| Metropolis Healthcare Ltd. | 0.96 | |
| Automobiles | 5.47 | |
| Hero MotoCorp Ltd. | 2.89 | |
| Maruti Suzuki India Limited | 2.58 | |
| Pharmaceuticals and Biotechnology | 4.42 | |
| Ipca Laboratories Ltd. | 1.49 | |
| JB CHEMICALS & PHARMACEUTICALS LTD. | 0.99 | |
| Ajanta Pharma Ltd. | 0.98 | |
| JUBILANT PHARMOVA LIMITED | 0.96 | |
| Petroleum Products | 4.10 | |
| RELIANCE INDUSTRIES LTD. | 3.02 | |
| Bharat Petroleum Corporation Ltd. | 1.08 | |
| Telecom - Services | 3.99 | |
| Bharti Airtel Ltd | 2.58 | |
| Indus Towers Ltd. | 1.41 | |
| Construction | 3.68 | |
| Larsen And Toubro Ltd. | 2.62 | |
| KALPATARU PROJECTS INTERNATIONAL LIMITED | 1.06 | |
| Cement and Cement Products | 3.63 | |
| Ultratech Cement Ltd. | 2.13 | |
| Dalmia Bharat Limited | 1.50 | |
| Consumer Durables | 3.13 | |
| VOLTAS LTD. | 1.17 | |
| Century Plyboards (India) Ltd. | 1.12 | |
| LG ELECTRONICS INDIA LTD | 0.84 | |
| Power | 2.62 | |
| NTPC LTD | 2.62 | |
| Ferrous Metals | 2.50 | |
| Jindal Steel & Power Ltd. | 1.51 | |
| Tata Steel Ltd. | 0.99 | |
| Retailing | 2.43 | |
| SWIGGY LTD | 1.85 | |
| VISHAL MEGA MART LIMITED | 0.58 | |
| Electrical Equipment | 2.37 | |
| GE VERNOVA T&D INDIA LIMITED | 2.14 | |
| EMMVEE PHOTOVOLTAIC POWER LIMITED | 0.23 | |
| Aerospace and Defense | 1.71 | |
| Bharat Electronics Ltd. | 1.71 | |
| Agricultural, Commercial and Construction Vehicles | 1.51 | |
| ASHOK LEYLAND LTD. | 1.51 | |
| Personal Products | 1.35 | |
| Godrej Consumer Products Ltd. | 1.35 | |
| Chemicals and Petrochemicals | 1.34 | |
| SRF Ltd. | 1.34 | |
| Transport Services | 1.27 | |
| Inter Globe Aviation Ltd | 1.27 | |
| Beverages | 1.11 | |
| Radico Khaitan Ltd. | 1.11 | |
| Non - Ferrous Metals | 1.05 | |
| Hindalco Industries Ltd | 1.05 | |
| Insurance | 1.01 | |
| SBI Life Insurance Company Ltd | 1.01 | |
| Capital Markets | 0.81 | |
| NUVAMA WEALTH MANAGEMENT LIMITED | 0.81 | |
| Diversified FMCG | 0.80 | |
| ITC Ltd. | 0.80 | |
| Fertilizers and Agrochemicals | 0.77 | |
| Coromandel International Ltd. | 0.77 | |
| Industrial Products | 0.64 | |
| HAPPY FORGINGS LTD | 0.64 | |
| Leisure Services | 0.63 | |
| SAPPHIRE FOODS INDIA LTD. | 0.63 | |
| Industrial Manufacturing | 0.59 | |
| JYOTI CNC AUTOMATION LTD | 0.59 | |
| Auto Components | 0.57 | |
| TENNECO CLEAN AIR INDIA LIMITED | 0.57 | |
| Equity & Equity related - Total | 98.35 | |
| Triparty Repo | 1.70 | |
| Net Current Assets/(Liabilities) | -0.05 | |
| Grand Total | 100.00 | |
| | ||
| Monthly SIP of (₹) 10000 | Since Inception | 10 years | 7 years | 5 years | 3 years | 1 year |
| Total amount invested (₹) | 24,80,000 | 12,00,000 | 8,40,000 | 6,00,000 | 3,60,000 | 1,20,000 |
| Total Value as on Feb 27, 2026 (₹) | 1,38,01,328 | 29,39,263 | 16,26,311 | 9,06,572 | 4,43,194 | 1,26,771 |
| Scheme Returns (%) | 14.54 | 17.08 | 18.57 | 16.57 | 14.05 | 10.78 |
| Nifty 500 (TRI) Returns (%) | 13.27 | 14.66 | 15.57 | 12.71 | 10.47 | 5.49 |
| Alpha* | 1.26 | 2.42 | 3.00 | 3.86 | 3.58 | 5.30 |
| Nifty 500 (TRI) (₹)# | 1,17,45,656 | 25,80,417 | 14,61,798 | 8,24,631 | 4,20,897 | 1,23,472 |
| Nifty 100 (TRI) Returns (%) | 12.86 | 13.58 | 13.97 | 11.49 | 9.98 | 5.68 |
| Alpha* | 1.68 | 3.50 | 4.60 | 5.07 | 4.07 | 5.11 |
| Nifty 100 (TRI) (Rs)# | 1,11,46,902 | 24,35,591 | 13,80,795 | 8,00,231 | 4,17,891 | 1,23,591 |
| Nifty 50 (TRI) (Rs)^ | 1,06,63,701 | 24,21,985 | 13,64,474 | 7,91,192 | 4,13,672 | 1,22,960 |
| Nifty 50 (TRI) Returns (%) | 12.51 | 13.47 | 13.64 | 11.04 | 9.28 | 4.67 |
Scheme Inception : - July 27,2005. The returns are calculated by XIRR approach assuming investment of ₹ ₹ 10,000/- on the 1st working day of every month. Since Inception returns are assumed to be starting from the inception date of the Scheme and
calculated accordingly. XIRR helps in calculating return on investments given an initial and final value and a series of cash inflows and outflows and taking the time of investment into consideration. The SIP performance details provided herein
are of Regular Plan - Growth Option Different plans have different expense structure. # Benchmark; ^ Additional Benchmark. TRI – Total Return Index, In terms of para 6.14 of SEBI Master circular No. SEBI/HO/IMD/IMD-PoD-1/P/CIR/2024/90
dated June 27, 2024, the performance of the scheme is benchmarked to the Total Return variant (TRI) of the Benchmark Index instead of Price Return Variant (PRI). Alpha is difference of scheme return with benchmark return. *All payouts during the
period have been reinvested in the units of the scheme at the then prevailing NAV. Source: ICRA MFI Explorer.
Net Asset Value (NAV)
| Regular | Direct | |
| Growth | Rs155.1026 | Rs184.3472 |
| IDCW | Rs53.4633 | Rs65.5997 |
Available Plans/Options
A) Regular Plan B) Direct Plan
Options: Payout of IDCW, Reinvestment of
IDCW & Growth (applicable for all plans)
| Fund Manager* | Ms. Shibani Sircar Kurian |
| Benchmark*** | Nifty 500 TRI (Tier 1), Nifty 100 TRI (Tier 2) |
| Allotment date | July 27, 2005 |
| AAUM | Rs5,206.61 crs |
| AUM | Rs5,224.68 crs |
| Folio count | 1,41,666 |
IDCW Frequency
Trustee's Discretion
Ratios
| Portfolio Turnover | 34.24% |
| $Beta | 1.00 |
| $Sharpe ## | 1.19 |
| $Standard Deviation | 13.04% |
| ^^(P/E) | 26.61 |
| ^^P/BV | 3.44 |
Market Capitalisation*
| Large Cap | 57.40% |
| Mid Cap | 29.08% |
| Small Cap | 11.87% |
| Debt & Money Market | 1.65% |
*% of Net Asset
Minimum Investment Amount
Initial & Additional Investment
• Rs100 and any amount thereafter
Systematic Investment Plan (SIP)
• Rs 100 and any amount thereafter
Ideal Investments Horizon
• 5 years & above
Load Structure
Entry Load:
Nil. (applicable for all plans)
Exit Load:
• For redemption / switch out within 90
days from the date of allotment:1%
• If units are redeemed or switched out on
or after 90 days from the date of allotment -
Nil.
Total Expense Ratio**
| Regular Plan: | 1.83% |
| Direct Plan: | 0.58% |
Data as on 28th February, 2026 unless
otherwise specified.
Folio Count data as on 31st January 2026.
Folio Count data as on 31st January 2026.
Fund
Benchmark - Tier 1 : Nifty 500 TRI
Benchmark - Tier 2 : Nifty 100 TRI
This product is suitable for investors who are seeking*:
Benchmark - Tier 1 : Nifty 500 TRI
Benchmark - Tier 2 : Nifty 100 TRI
This product is suitable for investors who are seeking*:
- Long term capital growth
- Investment in portfolio of predominantly equity & equity related securities.
* Investors should consult their financial advisors if in doubt about whether the product is suitable for them.
For latest Riskometer, investors may refer to an addendum issued or updated on website at www.kotakmf.com
***As per para 1.9 of of SEBI Master c***As per para 1.9 of of SEBI Master circular No. SEBI/HO/IMD/IMD-PoD-1/P/CIR/2024/90 dated June 27, 2024 The first tier benchmark is reflective of the category of the scheme and the second tier benchmark is demonstrative of the investment style / strategy of the Fund Manager within the category.
## Risk rate assumed to be 5.17% (FBIL Overnight MIBOR rate as on 27th Feb 2026).**Total Expense Ratio includes applicable B30 fee and GST.
* For Fund Manager experience, please refer 'For Regular Plan' & 'For Direct Plan'
For last three IDCW, please refer 'Dividend History'.
For scheme performance, please refer 'For Regular Plan' & 'For Direct Plan'